Odyssey Therapeutics, Inc. · CIK 1882782
Odyssey Therapeutics, Inc.
Filings
1
Original notices
1
Amendments
0
Activity
Dec 4, 2025
through Dec 4, 2025
through Dec 4, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $214,025,200
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $214,025,200
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Antares Therapeutics, Inc. · CIK 2059043
Form D filings (1)
-
0001104659-25-118426D · Dec 4, 2025 · BiotechnologyOffering: $214,025,200Sold: $214,025,200